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Background: The Canadian circumpolar Inuit population has a higher incidence rate of cervical cancer than the
general population and the majority of cases occur among underscreened women. The objectives of this study
were to determine Pap smear utilization rates and to determine factors associated with time-inappropriate use of
cervical cancer screening among a cohort of Inuit women from Nunavik, Quebec, Canada.
Methods: This study utilizes baseline information collected from a cohort formed between January 2002 and
December 2007 to study the natural history of HPV among Inuit women aged 21–69 years in Nunavik, Quebec.
Cervical cancer screening history and other variables were obtained from a baseline questionnaire and medical
chart review. Unconditional logistic regression was used to estimate the odds ratios and 95% confidence intervals
for potential predictors of not having a Pap smear within the previous 3 years prior to cohort entry.
Results: A total of 403 Inuit women who had a baseline questionnaire and chart review were included. The mean
age of the study population was 34.2 years. In the three years prior to study entry, 25% of women did not have a
Pap smear. Older age and never giving birth were significant predictors of time-inappropriate Pap smear use.
Conclusions: Our results suggest that older women and women who are not accessing reproductive care have a
lower compliance with time-appropriate cervical cancer screening and future research should address potential
strategies to increase screening coverage among this group.Background
Early detection of cervical cancer and pre-cancer by the
Papanicolaou (Pap) smear has led to the successful
reduction of cervical cancer incidence and mortality
throughout Canada. However, underutilization of cer-
vical cancer screening is still a major problem, as 60%
of cervical cancers occur in women who have not been
screened in the three previous years [1,2]. In Canada,
a variety of factors have been shown to predict
underutilization of cervical cancer screening, such as
older age, single marital status, lower educational
attainment, birth place outside Canada, Aboriginal
identity, rural residence, obesity and not having a fam-
ily doctor [3-6]. Additionally, the few studies that have* Correspondence: paul.brassard@mcgill.ca
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reproduction in any medium, provided the orlooked at reproductive and sexual behaviour factors
found that ever being pregnant, early age at first sexual
intercourse, use of birth control, number of sexual
partners, and history of sexually transmitted infection
(STIs) were associated with Pap smear use, although
not consistently [7,8].
Among the Canadian Inuit population, age-standardized
cervical cancer incidence rates are 2.5 to 3 times higher
than the national average [9,10]. Inuit populations also
face a higher cervical cancer mortality rate and a high
prevalence of human papillomavirus (HPV), a neces-
sary cause of cervical cancer [10-13]. About one-fifth
of Canada’s Inuit population resides in Nunavik, the
arctic and subarctic region of northern Quebec [14]. In
Quebec, there is no organized cervical cancer screen-
ing program, and thus in Nunavik, all Pap smear
screening is done opportunistically. The Pap test is
available in all 14 communities of Nunavik and is gen-
erally performed by nurse practitioners. As womenLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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review their charts and offer cervical cancer screening
if there is no history of Pap smear within the past
year. Screening is also promoted and offered during
prenatal and well-baby clinics. It is recommended that
women get screened in the month of their birth, but
there is no systematic follow-up or reminder system.
Additionally, in association with a study on the natural
history of HPV among Inuit women, members of the
research team conducted health promotion activities
around cervical cancer screening on the local radio
three times per year during study recruitment and
follow-up. Screening and treatment of cervical cancer
is available at no charge under the provincial health in-
surance plan (Régie de l’assurance maladie du Québec).
A recent meta-analysis on the relative risk of cervical
cancer among indigenous women of Australia, Canada,
New Zealand and the United States found that although
indigenous women had a high risk of invasive cervical
cancer and mortality from this disease, they were not at
an elevated risk of early-stage cervical cancer compared
to the general population [15]. The authors suggest that
this is likely the result of barriers to screening and
adequate treatment after diagnosis. Therefore, under-
standing the predictors of inappropriate screening use is
important, as groups of women who have lower compli-
ance to screening guidelines represent potential targets
for future screening interventions. Increasing their com-
pliance will be essential to reducing cervical cancer
incidence and mortality in Nunavik. The only known
study that has examined the determinants of Pap smear
utilization among Inuit women in Nunavik found that
higher education levels and younger age were associated
with screening within the previous two years [16]. Pap
smear history was obtained through self-report in that
study, which may introduce a recall bias because it has
been shown that women consistently over-report their
screening history [17,18]. Alternative methods to ascer-
tain screening history, such as medical record review or
linkage to screening registries would be preferable to
avoid measurement error. The purpose of this report
was to determine Pap smear utilization rates from med-
ical chart review and to determine factors associated
with time-inappropriate cervical cancer screening among
a cohort of Inuit women from Nunavik, Quebec.
Methods
This analysis utilizes baseline questionnaire and retro-
spective chart review data collected on a cohort of Inuit
women, which was created to examine the natural his-
tory of HPV in Nunavik [12,19,20]. Briefly, between
January 2002 and December 2007, a total of 621 Inuit
women between the ages of 15 and 69, who had an in-
tact uterus and no diagnostic suspicion for cervicalcancer were recruited to this cohort, when presenting
for a Pap smear (scheduled or otherwise). Full details
on cohort eligibility and data collection are available
elsewhere [12]. Written informed consent was obtained
from all study participants and ethical approval for this
study was obtained from the McGill Institutional Review
Board.
To be eligible for this sub-analysis women had to have
both a completed questionnaire and full medical chart
review, and be between 21 and 69 years of age. Women
under 21 years were excluded because they fall outside
of the recommended age to initiate cervical cancer
screening in Canada and in Quebec [21]. A three-year
screening interval commencing at age 18 prevailed as
the recommended screening procedure during the study
period in Quebec and Canada [1,21].
Sociodemographic, reproductive, medical, sexual his-
tory and lifestyle characteristics for participants were
obtained from a questionnaire administered at cohort
entry and a baseline medical chart review. During the
medical file review, a detailed history of cytology use
was collected and this information was used to develop
a binary outcome variable that distinguishes between
women who had their last Pap test within the three years
prior to cohort entry (time-appropriate) and those who
did not have a Pap test within the three previous years,
including those who never had a Pap test (time-
inappropriate). The candidate predictor variables analysed
in this study were age, marital status, employment status,
education level, smoking status, alcohol use, self-reported
history of STI, age at first sexual intercourse, number of
lifetime sexual partners, number of lifetime deliveries, use
of any birth control, and community of residence.
Descriptive statistics were obtained and chi-square
tests (categorical data) and t-tests (continuous data) were
used to assess associations between Pap testing and
covariates. Relationships between all covariates were ex-
plored with cross-tabulations of categorical variables and
correlation matrices of continuous variables to examine
the presence of collinearity and interaction [22]. Uncon-
ditional logistic regression was used to examine the
potential associations between all covariates and time-
inappropriate cervical cancer screening. The following
variables were selected for inclusion in the multivariate
model based on a priori evidence of association in
different populations: age, marital status and education
[3,4]. Additional variables were considered for inclusion
in the multivariate models if they were significantly asso-
ciated with time inappropriate Pap smear use in an age-
adjusted analysis (data not shown). Lifetime deliveries
and current use of birth control were found to exhibit a
high degree of collinearity, and thus only the lifetime de-
liveries covariate was included in the final model. Odds
ratios (OR) and 95% confidence intervals (95% CIs) were
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management and statistical analysis were performed
with SAS version 9.2 and statistical significance for all
regressions was set at 5%.
Results
Of the 621 cohort participants, 510 (82.1%) women had
a complete questionnaire and full medical file review
with cytological history. Among these women, 403 (79%)
were between the ages of 21 and 69 and were therefore
included in this analysis. All eligible women were sexu-
ally active prior to cohort entry. Selected demographic
characteristics are displayed in Table 1. The average age
was 34.2 years, with a range of 21 to 65 years. A total of
96 women (24.8%) had not had a Pap smear within the
three years prior to cohort entry. Among those who did
not receive a time-appropriate screening, 16 (16.7%) had
never received a Pap smear. The highest rate of time in-
appropriate Pap smear use by age group was seen among
women aged 45 and older (29.8%), followed by women
aged 30 to 44 years (27.5%). There was a lower rate of
time inappropriate cervical cancer screening among
women 21–29 years (17.9%).
Table 2 shows unadjusted and adjusted odds ratio
estimates for the association between candidate variables
and time-inappropriate Pap smear use. In the fully-
adjusted model, age was strongly associated with time-
inappropriate Pap smear use. Women aged 30 to 44 had
an over three times higher odds of having a time-
inappropriate Pap smear than women 21 to 29 years
(OR= 3.23, 95%CI: 1.72-6.04). Women 45 and older had
a significantly higher odds of time-inappropriate Pap
smear use in the univariate model (OR=1.99, 95%CI:
1.03-2.83), but this association did not maintain its sig-
nificance in the multivariate model (OR=2.28, 95%CI:
0.99-5.26). No history of childbirth was also found to be
a strong predictor of time-inappropriate Pap smear,
where women without a history of childbirth had over a
two times higher odds of having a time-inappropriate
Pap smear than women with a history of childbirth
(OR =2.57, 95%CI: 1.10-6.01). Community of residence
had an effect on cervical cancer screening in the univari-
ate analysis with community 1 having a significantly
higher odds of time-inappropriate Pap smear use than
community 2 (OR= 2.51, 95%CI: 1.01-6.22), but this
association was not significant in the multivariate model.
Discussion
The analysis presented here refers to Pap smear use
and determinants of time-inappropriate cervical cancer
screening among Inuit women aged 21–69 in Nunavik,
Quebec. Overall, there was a sizeable high-risk group
who had not been screened in the three years prior to
cohort entry (25%), and 4% of the sample had neverbeen screened for cervical cancer. Although Aboriginal
populations in Canada have traditionally had lower
screening rates than the general population, we found
that the cervical cancer screening coverage in this
population was comparable to the screening coverage
reported for the Canadian population [3,4,23]. How-
ever, there is still cause for concern, given that there is
a high prevalence of high-risk HPV (HR-HPV) infec-
tion and incidence of cervical cancer in this population
[9,10,12]. If high-risk subsets of the population are
systematically underscreened for cervical cancer, then
it is likely that incidence and mortality reductions will
not be observed, despite screening rates that are compar-
able with the general population of Canada. Understanding,
the predictors of screening underuse will help determine
opportunities to adapt or enhance health promotion activ-
ities for screening among underserved groups.
In this population, older age and no history of child-
birth were significant predictors of time-inappropriate
Pap smear use. We found that older women had a sig-
nificantly higher odds of not being screened appropri-
ately compared to younger women. A similar effect of
Pap smear rates decreasing with age was found in other
Canadian populations [4,24]. It is worrisome that older
women are at risk of not being screened appropriately,
as cervical cancer mortality increases with age and cer-
vical cancer incidence is higher among women 40 years
and older [25]. Menopausal or post-menopausal women
may not always realize that screening is still necessary
after reproductive years [26], as younger women may be
more aware of the need for periodic screening.
Our results also suggest that screening may be related
to reproductive care use, given that women who had no
history of child birth were more likely to have had a
time-inappropriate Pap smear. In Nunavik, Pap smear is
offered as part of the prenatal and well-baby visits, so
women who access these services would likely have mul-
tiple opportunities to be screened. Similarly, women
from Ontario without a prenatal visit during a three
year interval were also less likely to have been screened
for cervical cancer than those who did attend a pre-
natal visit [24]. Although we were unable to include
use of birth control in the final model due to collinear-
ity, in the univariate analysis we found that women
who did not use birth control at baseline had an in-
creased odds of having time-inappropriate screening.
This is consistent with a previous study which found
that women participated in screening because it was
linked with the annual renewal of their oral contractive
prescription [27]. Indeed, the majority of women in
our study (78%) who used birth control used a hormo-
nal birth control type (oral contraceptive or Depo-
Provera injections), which might explain some of this
relationship.
Table 1 Demographic characteristics of all study participants and by history of Pap smear within the previous three
years (n=403)
All women
(n = 403 )
Women screened in previous 3 years
(n = 307) n(%)
Women not screened in previous 3 years
(n = 96) n(%)
Age Category†
21-29 168 138 (82.1) 30 (17.9)
30-44 178 129 (72.5) 49 (27.5)
45+ 57 40 (70.2) 17 (29.8)
Marital status
Married or living with
partner
253 190 (75.1) 63 (24.9)
Single 144 112 (77.8) 32 (22.2)
Missing 6 5 (83.3) 1 (16.7)
Educational attainment
< Grade 9 126 91 (72.2) 35 (27.8)
≥ Grade 9 266 209 (78.6) 57 (21.4)
Missing 11 7 (63.6) 4 (36.4)
Employed
Yes 306 226 (73.9) 80 (26.1)
No 89 73 (82.0) 16 (18.0)
Missing 8 8 (100.0) 0 (0.0)
Current smoker
Yes 295 226 (76.6) 69 (23.4)
No 101 77 (76.2) 24 (23.8)
Missing 7 4 (57.1) 3 (42.9)
Current alcohol use
Yes 303 232 (76.6) 71 (23.4)
No 95 71 (74.7) 24 (25.3)
Missing 5 4 (80.0) 1 (20.0)
Self-reported history of STI
Yes 302 234 (77.5) 68 (22.5)
No 86 60 (69.8) 26 (30.2)
Missing 15 13 (86.7) 2 (13.3)
Lifetime no. of sexual
partners
Less than 10 220 166 (75.5) 54 (24.5)
10 or more 151 116 (76.8) 35 (23.2)
Missing 32 25 (78.1) 7 (21.9)
Age at first sexual
intercourse††
< 16 years 196 156 (79.6) 40 (20.4)
≥16 years 182 131 (72.0) 51 (28.0)
Missing 25 20 (80.0 5 (20.0)
Previously given birth
Yes 364 281 (77.2) 83 (22.8)
No 38 25 (65.8) 13 (34.2)
Missing 1 1 (100.0) 0 (0.0)
Cerigo et al. BMC Public Health 2013, 13:438 Page 4 of 8
http://www.biomedcentral.com/1471-2458/13/438
Table 1 Demographic characteristics of all study participants and by history of Pap smear within the previous three
years (n=403) (Continued)
Current use of birth control
Yes 167 138 (82.6) 29 (17.4)
No 221 157 (71.0) 64 (29.0)
Missing 15 12 (80.0) 3 (20.0)
Community
1 212 157 (74.1) 55 (25.9)
2 49 43 (87.8) 6 (12.2)
3 96 71 (74.0) 25 (26.0)
4 44 34 (77.3) 10 (22.7)
Missing 2 2 (100.0) 0 (0.0)
+ Mean (SD): 34.19 (9.56), Median: 32.12, Range: 21–65.
++ Mean (SD): 15.51 (2.23), Median: 15, Range: 10–30.
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or less educated women were less likely to have time-
appropriate screening [4]. Although we were unable to
investigate this finding further, differences in demo-
graphic and family structure characteristics of Nunavik,
compared to the Canadian population in general may
explain this null result [28,29].
Geographic variation in screening rates was found in the
univariate analysis, with one community being highly
predictive of time-inappropriate cervical cancer screening,
but this association did not maintain significance in the
multivariate analysis. Although this study was not able to
uncover the factors that contribute to these variations, previ-
ous studies suggest that community size [7], access to
female health providers [30], perceived importance of
screening by health providers [31], and promotion of screen-
ing in the community [32] may play a role. The population
size of each community is small (under 2500 people) and
health centres are easily accessible by foot in all communi-
ties. In the univariate model women from the largest com-
munity were found to have a significantly lower odds of
time-appropriate Pap smears, suggesting that community
size may contribute to the variation by community. The two
other communities also showed an elevated, but non-
significant odds of time-inappropriate Pap smear use com-
pared to the referent community in both the univariate and
multivariate analysis. However, communities 2, 3 and 4 had
similar population sizes and therefore size may not be the
only factor contributing to the effect of community. Factors
such as attitudes around screening in the community and
characteristics of the health centre staff are likely to also
contribute to these differences. It has been previously shown
that Inuit women have a strong preference for having
screening performed by a female provider [30]. Although,
we were unable to assess the gender ratio of providers in
these communities during data collection, the presence of a
male provider may have led to a delay in screeningacceptance among some women, which could help explain
some of our findings. In the 2004 Nunavik Health Survey,
41% of women who had a Pap smear two or more years ago
or never reported that cervical cancer screening was not of-
fered by their doctors [16]. The factors related to the rela-
tionship between women and their health care providers are
especially important because women can only access health
care from their community’s health centre.
A limitation of this study was that women were recruited
non-randomly, while attending any visit at the health centre
that necessitated a Pap smear. Given that our sample was
comprised of women who consented to the cohort study, it
is likely that we underestimated the proportion of women
who have never had a Pap test. It is difficult to assess the
extent of this underestimation given that there is no cer-
vical screening registry in Quebec; however, one randomly-
selected population based study found that 6.8% of women
aged 18–29 years across Nunavik were never screened [16],
whereas a convenience-sample of women 18–63 years in
two communities of Nunavik found that only 3.4% had not
previously received a Pap test [30]. Our results are within
the range reported among other samples in Nunavik, but
caution must be exercised in comparison of these results
due to the reported age-differences and the self-reported
nature of cervical cancer screening history in these studies.
Also, our sample was comparable to the general population
of women in Nunavik, with the exception of an underrepre-
sentation of women ages 45 and older [29]. The sample
size was small, but we had a fairly high overall cover-
age of the population, given that our study sample rep-
resented 50.5% of women aged 20–69 in the four
recruitment communities. Furthermore, we assessed
time-inappropriate screening as not having a Pap
smear within the previous 3 years, but if we had a lar-
ger sample it would have been important to assess
screening compliance in situations where a shorter
interval is needed, such as the follow-up of an
Table 2 Determinants of time-inappropriate Pap smear use+ among Inuit women in Nunavik, Quebec (n=403)
OR (95% CI)++
Variable Crude Fully-adjusted
Age 1.38 (1.09 -1.74)
21-29 Reference Reference
30-44 2.63 (1.56-4.44) 3.23 (1.72-6.04)
45+ 1.99 (1.03-3.83) 2.28 (0.99-5.26)
Marital status at baseline
Married or living with partner Reference Reference
Single 0.86 (0.53-1.40) 0.89 (0.49-1.62)
Educational attainment
< Grade 9 Reference Reference










Self-reported history of STI
No Reference
Yes 0.67 (0.39-1.14)
Age at first sexual intercourse (per year) 1.10 (0.98-1.21)
Lifetime # of sexual partners
< 10 partners Reference
≥ 10 partners 0.93 (0.57-1.51)
Previously given birth
Yes Reference Reference
No 1.76 (0.86-3.59) 2.57 (1.10-6.01)




1 2.51 (1.01-6.22) 1.82 (0.69-4.82)
2 Reference Reference
3 2.52 (0.96-6.64) 1.95 (0.69-5.48)
4 2.11 (0.70-6.38) 1.16 (0.33-4.16)
+ No history of Pap smear within the three years prior to cohort entry.
++Odds ratio (95% Confidence Interval). Odds ratios are unadjusted or fully adjusted for all other variables in the model.
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sult, where it is recommended that women have a re-
peat cytology within 6 to 12 months [21].
A major strength of this study was the use of a retro-
spective medical chart review to determine women’scervical cancer screening history. Given that women tend
to over-report their screening history, by obtaining this
variable through chart review, we have reduced bias due to
measurement error of the outcome variable. As this ana-
lysis was part of a larger research program on HPV and
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questionnaire data and thus investigate the association with
sexual health and reproductive history factors. This study
is one of the few studies to be able to analyse the asso-
ciation between these behaviours and Pap screening.
Despite the sensitive nature of many of these
covariates, we had relatively low levels of missing data
(range: 0-8%).
Understanding screening patterns and groups noncom-
pliant with screening is highly relevant to future efforts to
reduce the higher cervical cancer incidence and mortality
among Inuit women in Nunavik. Although we found
screening rates in Nunavik to be comparable to that of the
Canadian population, there is cause for concern given the
higher incidence of cervical cancer. Further investigation is
needed to determine if factors that take place after screen-
ing, such as time to treatment, contribute to the differential
risk of cervical cancer mortality between these populations.Conclusions
Given that older women and women who are not
accessing reproductive care have a lower compliance
with time-appropriate cervical cancer screening, future
research should address potential strategies to increase
Pap smear use or other screening technique such as
HPV testing [21] among this group. Deployment of the
latter test, owing to its higher sensitivity relative to cy-
tology could permit safely extending screening intervals
[33,34]. Moreover, it can be performed in self-collected
cervicovaginal samples, which would permit increased
coverage to women in remote areas or to those who re-
sist attending screening. We intend to evaluate the po-
tential for such practical screening strategies as a means
to provide more cost-effective cervical cancer prevention
to these disadvantaged communities.Competing interests
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